Showing results (431-440 of 449) with videos related to
Sort By:
Pageof 45
Nature Communications|November 20, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targetsBieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.Cancers|April 30, 2021
Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and AustriaMadlen Reschke, Eva Biewald, Leo Bronstein, et al.Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.Nature Communications|July 25, 2022
Therapeutic targeting of ATR in alveolar rhabdomyosarcomaHeathcliff Dorado García, Fabian Pusch, Yi Bei, et al.Oncotarget|August 31, 2016
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastomaJohannes Fabian, Desirée Opitz, Kristina Althoff, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Survival time in cystinosis. A collaborative studyN Gretz, F Manz, R Augustin, et al.Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.Nature|October 16, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Falk Hertwig, Frederik Roels, et al.Pageof 45